Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Indegene Shares In Focus As IDBI Capital Initiates Coverage — Check Target Price, Upside And More

    13 hours ago

    The brokerag highlighted that Indegene is the only listed, pure-play life sciences commercialisation company at scale, with global rivals like EVERSANA and Syneos, and its 18%+ earnings growth comfortably supporting a valuation toward the lower-middle end of Indian IT-services peer range.
    Click here to Read More
    Previous Article
    Asian Paints Shares Fall Nearly 3% Despite Q1 Earnings Beat — Should You Buy?
    Next Article
    Stock Market News Today Live Updates: Nifty Below 24,200, Sensex Falls 200 Points; Thangamayil Jewellery Slumps Over 9%

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment